- Home
- YMAB vs RMR Comparison
YMAB vs RMR Comparison
Compare YMAB & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- RMR
- Stock Information
- Founded
- YMAB 2015
- RMR 1986
- Country
- YMAB United States
- RMR United States
- Employees
- YMAB N/A
- RMR N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- RMR Professional Services
- Sector
- YMAB Health Care
- RMR Consumer Discretionary
- Exchange
- YMAB Nasdaq
- RMR Nasdaq
- Market Cap
- YMAB 270.5M
- RMR 281.5M
- IPO Year
- YMAB 2018
- RMR N/A
- Fundamental
- Price
- YMAB $4.43
- RMR $16.65
- Analyst Decision
- YMAB Buy
- RMR Buy
- Analyst Count
- YMAB 11
- RMR 2
- Target Price
- YMAB $18.73
- RMR $32.00
- AVG Volume (30 Days)
- YMAB 328.7K
- RMR 188.4K
- Earning Date
- YMAB 03-04-2025
- RMR 05-06-2025
- Dividend Yield
- YMAB N/A
- RMR 10.79%
- EPS Growth
- YMAB N/A
- RMR N/A
- EPS
- YMAB N/A
- RMR 0.97
- Revenue
- YMAB $87,685,000.00
- RMR $199,940,000.00
- Revenue This Year
- YMAB $20.07
- RMR $371.91
- Revenue Next Year
- YMAB $8.76
- RMR $1.02
- P/E Ratio
- YMAB N/A
- RMR $17.13
- Revenue Growth
- YMAB 3.38
- RMR N/A
- 52 Week Low
- YMAB $4.25
- RMR $16.22
- 52 Week High
- YMAB $17.78
- RMR $26.43
- Technical
- Relative Strength Index (RSI)
- YMAB 34.59
- RMR 34.92
- Support Level
- YMAB $4.65
- RMR $16.22
- Resistance Level
- YMAB $5.25
- RMR $17.07
- Average True Range (ATR)
- YMAB 0.30
- RMR 0.42
- MACD
- YMAB 0.03
- RMR -0.03
- Stochastic Oscillator
- YMAB 6.32
- RMR 24.23
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.